AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11146577 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estrogen with and without progestogen
Number of subjects: 64
Study 9832298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (2 mg x kg(‐1)) during the acute phase
Number of subjects: 12
Study 9832298 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (2 mg x kg(‐1)) during the acute phase
Number of subjects: 12
Study 9832298 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (2 mg x kg(‐1)) after remission
Number of subjects: 12
Study 8077885 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 1.2 mg day-1 to 2.0 mg day-1 (n = 9)
Number of subjects: 21
Study 8077885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 21
Study 2812839 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of lactulose
Number of subjects: 12
Study 2812839 — intervention group
Group type: COMPARATOR
Intervention: 0 g of lactulose (placebo)
Number of subjects: 12
Study 779998 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed cholera vaccine
Number of subjects: 0
Study 779998 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral live cholera vaccine
Number of subjects: 0
Study 779998 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral cholera vaccine
Number of subjects: 0
Study 779998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30543266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided hypertonic dextrose (20%) injection
Number of subjects: 31
Study 30543266 — intervention group
Group type: COMPARATOR
Intervention: 5% normal saline injection
Number of subjects: 31
Study 28454576 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-fipronil combination (Effitix®) - treated three times every 4 weeks with a spot-on containing 54.5% permethrin and 6.1% fipronil.
Number of subjects: 30
Study 28454576 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (Control group B).
Number of subjects: 30
Study 25175425 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 146
Study 25175425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MADRS (depressive symptoms)
Number of subjects: 522
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline QLS (functioning/QOL)
Number of subjects: 522
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early improvement in QLS (week 2)
Number of subjects: 522
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early improvement in SWN-K (subjective well-being, week 2)
Number of subjects: 522
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early improvement in PANSS (symptoms, week 2)
Number of subjects: 522
Study 23293013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early improvement in CGI-S (overall clinical status, week 2)
Number of subjects: 522
Study 21707928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once a day for 12 weeks
Number of subjects: 217
Study 21707928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 18839134 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3548
Study 18839134 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 3548
Study 18839134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3548
Study 18839134 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 3548
Study 16961291 — intervention group
Group type: COMPARATOR
Intervention: Control group received a combination of 10% glucose, Vitamin C, and Inosine
Number of subjects: 68
Study 12955254 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescent in situ hybridisation for 22q11 deletion
Number of subjects: 64
Study 11130385 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil
Number of subjects: 1083
Study 11130385 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine-proguanil
Number of subjects: 1083
Study 9412897 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium salts administration after CPB
Number of subjects: 0
Study 9412897 — intervention group
Group type: COMPARATOR
Intervention: Calcium administration
Number of subjects: 0
Study 9412897 — intervention group
Group type: COMPARATOR
Intervention: Calcium influx during ischemia-reperfusion
Number of subjects: 0
Study 8331125 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 0
Study 8331125 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 0
Study 8331125 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 3108105 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg Sorbinil daily for 1 year
Number of subjects: 19
Study 3108105 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 year
Number of subjects: 19
Study 31907074 — intervention group
Group type: EXPERIMENTAL
Intervention: TANDEM intervention (tailored cognitive behavioural approach) delivered weekly for 6-8 weeks by trained respiratory healthcare professionals
Number of subjects: 430
Study 31907074 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 430
Study 31907074 — intervention group
Group type: EXPERIMENTAL
Intervention: TANDEM intervention
Number of subjects: 430
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA-derived indicators (excluding percentage of total body fat)
Number of subjects: 1207
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA-derived visceral adipose tissue measures (VAT, VAT/Total fat, visceral-to-subcutaneous fat)
Number of subjects: 1207
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: VAT/Total fat
Number of subjects: 1207
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: VAT
Number of subjects: 1207
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipodystrophy indicators (Trunk/Legs fat and Android/Gynoid fat)
Number of subjects: 1207
Study 30031660 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk/Legs fat
Number of subjects: 1207
Study 26968809 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema-Based Instruction (SBI)
Number of subjects: 806
Study 26968809 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 806
Study 25844834 — intervention group
Group type: EXPERIMENTAL
Intervention: BASICS (n = 115)
Number of subjects: 225
Study 25844834 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control (n = 110)
Number of subjects: 225
Study 24269077 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, individual dietary counseling (1 hour per week) and daily oral nutritional supplement (2531 kJ, 33.8 g protein, 2.2 g EPA)
Number of subjects: 61
Study 24269077 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, individual dietary counseling
Number of subjects: 61
Study 22648703 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching recovery techniques (TRT) intervention; 16 extracurriculum sessions
Number of subjects: 482
Study 22648703 — intervention group
Group type: COMPARATOR
Intervention: Normal school-provided support (waitlist control)
Number of subjects: 482
Study 19938921 — intervention group
Group type: EXPERIMENTAL
Intervention: Past sexual assault perpetration
Number of subjects: 72
Study 19938921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute alcohol consumption
Number of subjects: 72
Study 19938921 — intervention group
Group type: EXPERIMENTAL
Intervention: Hostility and misperception of women's sexual cues
Number of subjects: 72
Study 19938921 — intervention group
Group type: EXPERIMENTAL
Intervention: Misperception of women's sexual intentions
Number of subjects: 72
Study 17276552 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose hepatitis B immunisation (20 microg HBsAg doses 6 months apart)
Number of subjects: 384
Study 17276552 — intervention group
Group type: COMPARATOR
Intervention: Three-dose hepatitis B immunisation (10 microg HBsAg doses at 0, 1, 6 months)
Number of subjects: 384
Study 12677149 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg/d) for 12 weeks postoperatively
Number of subjects: 37
Study 12677149 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37
Study 10819700 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 8677636 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 U nHuIFN alpha
Number of subjects: 32
Study 8677636 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 U nHuIFN alpha
Number of subjects: 32
Study 8677636 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 U nHuIFN alpha
Number of subjects: 32
Study 8677636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 1615132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (0, 25, 50, 100 micrograms/70 kg)
Number of subjects: 13
Study 1615132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 6496915 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine during intravenous regional analgesia
Number of subjects: 52
Study 3514155 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05 percent ointment
Number of subjects: 130
Study 3514155 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate 0.05 percent ointment
Number of subjects: 130
Study 28745131 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity intervention with face-to-face and telephone PA counselling
Number of subjects: 32
Study 28745131 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study 27009675 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaxial 1.8 mm Micro‐Incision Cataract Surgery (C‐MICS)
Number of subjects: 30
Study 27009675 — intervention group
Group type: COMPARATOR
Intervention: Standard 2.75 mm Incision Cataract Surgery (SICS)
Number of subjects: 30
Study 25118091 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured assessment instrument for case conferences
Number of subjects: 360
Study 25118091 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative approach for case conferences
Number of subjects: 360
Study 24084921 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE plus MPA (0.625 mg/d CEE + 2.5 mg/d MPA)
Number of subjects: 27347
Study 24084921 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE alone (0.625 mg/d CEE)
Number of subjects: 27347
Study 20801233 — intervention group
Group type: EXPERIMENTAL
Intervention: Police-patrolled walking plus social marketing intervention
Number of subjects: 0
Study 20801233 — intervention group
Group type: COMPARATOR
Intervention: Police-patrolled walking only intervention
Number of subjects: 0
Study 20801233 — intervention group
Group type: COMPARATOR
Intervention: General health education only (no-walking intervention)
Number of subjects: 0
Study 18714249 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 20
Study 18714249 — intervention group
Group type: COMPARATOR
Intervention: No-stretch
Number of subjects: 20
Study 16618262 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg per tablet (AAC)
Number of subjects: 1555
Study 16618262 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg per tablet (IB)
Number of subjects: 1555
Study 16618262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1555
Study 12701006 — intervention group
Group type: EXPERIMENTAL
Intervention: Three consecutive 1‐minute dilations per session at 1‐minute intervals, at 200 mmHg for the first dilation and 300 mmHg for the second and third (Group A)
Number of subjects: 43
Study 12701006 — intervention group
Group type: COMPARATOR
Intervention: One dilation at 200 mmHg for 2 minutes (Group B)
Number of subjects: 43
Study 10984011 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol treatment
Number of subjects: 40
Study 10984011 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol treatment
Number of subjects: 40
Study 9428032 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐HI (programmable multiband full‐dynamic range compression behind‐the‐ear hearing instrument)
Number of subjects: 34
Study 9428032 — intervention group
Group type: COMPARATOR
Intervention: C‐mode (linear amplification mode)
Number of subjects: 34
Study 9428032 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐mode (non-linear amplification mode)
Number of subjects: 34
Study 1403041 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide with high-dose cyclosporine (CsA)
Number of subjects: 16
Study 3907505 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular methotrexate
Number of subjects: 82
Study 3907505 — intervention group
Group type: COMPARATOR
Intervention: Oral methotrexate
Number of subjects: 82
Study 31730666 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lactic acid gel
Number of subjects: 33
Study 31730666 — intervention group
Group type: COMPARATOR
Intervention: Oral metronidazole antibiotic
Number of subjects: 33
Study 29214863 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management intervention with 28, 1-hour classes tailored for extremes of the Dietary Guidelines' fat recommendations, including supervised and self-directed exercise sessions over 12 months.
Number of subjects: 101
Study 29214863 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management intervention
Number of subjects: 101
Study 29214863 — intervention group
Group type: COMPARATOR
Intervention: Lower fat group
Number of subjects: 101
Study 29214863 — intervention group
Group type: COMPARATOR
Intervention: Moderate fat group
Number of subjects: 101
Study 27317968 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine (150mg daily)
Number of subjects: 40
Study 27317968 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (150mg daily)
Number of subjects: 40
Study 25148467 — intervention group
Group type: EXPERIMENTAL
Intervention: Preplanned COD drills (CODG, n = 12)
Number of subjects: 36
Study 25148467 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sided games (SSGG, n = 12)
Number of subjects: 36
Study 25148467 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONG, n = 12)
Number of subjects: 36
Study 21370309 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy Massage (AM)
Number of subjects: 39
Study 21370309 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 39
Study 20438378 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial HIV therapy strategies (specific strategies not detailed in the abstract)
Number of subjects: 1357
Study 18718094 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab plus CHOP (R-CHOP)
Number of subjects: 69
Study 18718094 — intervention group
Group type: COMPARATOR
Intervention: CHOP alone (CHOP group)
Number of subjects: 69
Study 16685985 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D statistical atlas of cardiac anatomy
Number of subjects: 26
Study 12807526 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg eletriptan (E40)
Number of subjects: 446
Study 12807526 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan (E80)
Number of subjects: 446
Study 12807526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study 10806014 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 731
Study 10806014 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 731
Study 10806014 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise testing results
Number of subjects: 731
Study 10806014 — intervention group
Group type: EXPERIMENTAL
Intervention: Anginal pain
Number of subjects: 731
Study 10806014 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term treatment effects on ischaemia
Number of subjects: 731
Study 8969978 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with erythropoietin
Number of subjects: 0
Study 8969978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1672389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination of children aged between 0 and 4 years
Number of subjects: 358
Study 1672389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination of children between 1 and 9 months old
Number of subjects: 358
Study 1672389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination regimens
Number of subjects: 358
Study 1672389 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination against HBV
Number of subjects: 358
Study 6141797 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation (Normoc)
Number of subjects: 10
Study 6141797 — intervention group
Group type: COMPARATOR
Intervention: Standard preparation (commercially available)
Number of subjects: 10
Study 31371164 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation combined with music for 20 minutes, for a total of eight weeks in group sessions
Number of subjects: 56
Study 31371164 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched education (control group) for 20 minutes
Number of subjects: 56
Study 28826313 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (1,200 mg daily for 8 weeks)
Number of subjects: 42
Study 28826313 — intervention group
Group type: COMPARATOR
Intervention: Placebo (paraffin)
Number of subjects: 42
Study 28826313 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 42
Study 28826313 — intervention group
Group type: COMPARATOR
Intervention: Omega-3 supplementation and Placebo
Number of subjects: 42
Study 26208048 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg per day for the first week, followed by 40 mg per day from weeks 2 through 12
Number of subjects: 265
Study 26208048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 23841970 — intervention group
Group type: EXPERIMENTAL
Intervention: Horseback riding therapy (HBRT) plus conventional physiotherapy for 16 weeks
Number of subjects: 24
Study 23841970 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (control)
Number of subjects: 24
Study 23841970 — intervention group
Group type: EXPERIMENTAL
Intervention: Horseback riding therapy (HBRT) plus conventional physiotherapy
Number of subjects: 24
Study 21350878 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 68
Study 21350878 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 68
Study 19346285 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted indirect comparison using classic frequentist methods (n=49)
Number of subjects: 88
Study 19346285 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted indirect comparison using more complex methods (n=18)
Number of subjects: 88
Study 19346285 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal indirect comparison
Number of subjects: 88
Study 19346285 — intervention group
Group type: COMPARATOR
Intervention: Naive comparison without common control
Number of subjects: 88
Study 19346285 — intervention group
Group type: EXPERIMENTAL
Intervention: Head to head comparison trials
Number of subjects: 88
Study 17649636 — intervention group
Group type: EXPERIMENTAL
Intervention: h-R3 plus radiotherapy
Number of subjects: 137
Study 17649636 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (Control)
Number of subjects: 137
Study 15506603 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 1068
Study 11735640 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 0
Study 11735640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9156142 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid detection of pneumococcal antigen by latex agglutination
Number of subjects: 110
Study 7525661 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous FK506 (20 micrograms/kg x 4 hours)
Number of subjects: 6
Study 7525661 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral FK506 (80 micrograms/kg)
Number of subjects: 6
Study 7525661 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control mentioned)
Number of subjects: 6
Study 3310632 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g four times daily (group A, n = 131)
Number of subjects: 222
Study 3310632 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g twice daily (group B, n = 128)
Number of subjects: 222
Study 3310632 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g four times daily (group A)
Number of subjects: 222
Study 3310632 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g twice daily (group B)
Number of subjects: 222
Study 31132095 — intervention group
Group type: EXPERIMENTAL
Intervention: Black text on white background (BW)
Number of subjects: 1854
Study 31132095 — intervention group
Group type: EXPERIMENTAL
Intervention: Black on yellow (BY)
Number of subjects: 1854
Study 31132095 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel shape
Number of subjects: 1854
Study 31132095 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal word present
Number of subjects: 1854
Study 31132095 — intervention group
Group type: COMPARATOR
Intervention: Shape and signal word
Number of subjects: 1854
Study 29043600 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine hydrochloride SGB
Number of subjects: 96
Study 29043600 — intervention group
Group type: COMPARATOR
Intervention: Saline SGB
Number of subjects: 96
Study 27187435 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian green propolis (900 mg/day)
Number of subjects: 65
Study 27187435 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 25887113 — intervention group
Group type: EXPERIMENTAL
Intervention: TriAtiva Program: Education, Nutrition and Physical Activity
Number of subjects: 0
Study 25887113 — intervention group
Group type: COMPARATOR
Intervention: Control group (six schools)
Number of subjects: 0
Study 23415048 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time MRI-guided interstitial brachytherapy
Number of subjects: 25